Addressing Neurologic Toxicities in CAR-T Therapy: Monitoring, Management, and Patient Communication

News
Video

The discussion focuses on monitoring and managing neurologic toxicities like ICANS in CAR-T therapy, highlighting tools for early detection, effective management strategies, and approaches to communicating risks with patients and caregivers.

Video content above is prompted by the following:

  • Neurologic toxicities, such as ICANS, pose unique challenges. How do you approach monitoring and management of these events in your practice?
  • What tools or assessment methods help you identify early signs of neurotoxicity?
  • How do you communicate these risks to patients and their caregivers?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Related Content